Paliperidone 3-Month Im Injection Suppliers & Bulk Manufacturers
Available Forms: Once-3-Month IM Injection
Available Strengths: 273 mg, 410 mg, 546 mg, 819 mg
Reference Brands: Trevicta®(EU); Invega Trinza®(US)
Category: Antipsychotropic Drugs
Paliperidone is an atypical antipsychotic that works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, helping to reduce psychotic symptoms and stabilize mood. The 3-month intramuscular injection is used for the maintenance treatment of schizophrenia in adults who are already stabilized on the 1-month formulation. It ensures consistent therapeutic levels, improves patient adherence, and lowers relapse risk by reducing dosing frequency to four times a year.
Product Description: Paliperidone 3-month intramuscular injection (brand name: Invega Trinza) is FDA-approved in the United States for the maintenance treatment of schizophrenia in adults who have been stabilized on Invega Sustenna (1-month formulation) for at least four months. In the European Union, it is centrally approved by the EMA with established Risk Management Plans (RMPs) and required pharmacovigilance activities. Regulatory compliance includes GMP-certified long-acting injectable manufacturing, bridging pharmacokinetic and safety data, and documentation for relapse prevention. U.S. labeling includes a boxed warning for elderly patients with dementia-related psychosis. Explore dossier-ready options at Pharmatradz.com — your global B2B pharma hub.
Paliperidone 3-Month Im Injection — third party manufacturing & bulk supply
Paliperidone 3-Month Im Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Paliperidone 3-Month Im Injection is supplied as Once-3-Month IM Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Paliperidone 3-Month Im Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Paliperidone 3-Month Im Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View Details
Phenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
